Table 2.
Time point | Alcohol condition | Control condition | |||||
---|---|---|---|---|---|---|---|
n | M | SD | n | M | SD | ||
Main EP | |||||||
Perceived trustworthiness | 1 | 56 | 95.18 | 13.96 | 20 | 95.70 | 14.13 |
3 | 56 | 92.25 | 17.23 | 20 | 91.80 | 14.29 | |
Oxytocin concentration (in pg/mL) | 1 | 54 | 682 | 1169 | 19 | 383 | 354 |
2 | 54 | 1000 | 2662 | 19 | 934 | 2025 | |
3 | 54 | 811 | 1776 | 19 | 1122 | 1737 | |
Additional EP | |||||||
Testosterone concentration (in pg/mL) | 1 | 55 | 343 | 149 | 20 | 289 | 141 |
2 | 55 | 380 | 220 | 20 | 340 | 144 | |
3 | 55 | 366 | 215 | 20 | 359 | 155 | |
DHT concentration (in pg/mL) | 1 | 55 | 743 | 289 | 20 | 699 | 257 |
2 | 55 | 774 | 411 | 20 | 726 | 281 | |
3 | 55 | 728 | 329 | 20 | 905 | 502 | |
Positive affect | 1 | 56 | 3.36 | 0.67 | 20 | 3.14 | 0.60 |
3 | 56 | 3.69 | 0.82 | 20 | 2.96 | 0.59 | |
Risk-taking | 1 | 56 | 89.77 | 18.94 | 20 | 89.10 | 22.11 |
3 | 56 | 95.25 | 23.15 | 20 | 86.75 | 22.33 |
EP = endpoints; n = number of participants with available data; M = mean; SD = standard deviation; possible range of instruments: perceived trustworthiness (30–150), positive affect (1–5), risk-taking (30–210). For the analysis of the oxytocin concentration and the testosterone as well as DHT concentrations, three or one additional subject(s), respectively, were excluded because of missing values for at least one of the three time points